Phenotypic analysis of U-CLL and M-CLL cases
| Marker . | U-CLL cells . | M-CLL cells . | P . |
|---|---|---|---|
| IgM | 78.9 ± 4 | 59.4 ± 6.6 | < .02 |
| CD21 | 84.8 ± 3.8 | 85.4 ± 2.7 | NS |
| CD79b | 72.5 ± 4 | 68.6 ± 4.4 | NS |
| CD81 | 67.6 ± 4 | 78.4 ± 3.6 | < .05 |
| CD38 | 44.1 ± 6.5 | 19.5 ± 4.4 | < .001 |
| ZAP-70 | 27.5 ± 5.6 | 7.1 ± 2.9 | < .001 |
| Marker . | U-CLL cells . | M-CLL cells . | P . |
|---|---|---|---|
| IgM | 78.9 ± 4 | 59.4 ± 6.6 | < .02 |
| CD21 | 84.8 ± 3.8 | 85.4 ± 2.7 | NS |
| CD79b | 72.5 ± 4 | 68.6 ± 4.4 | NS |
| CD81 | 67.6 ± 4 | 78.4 ± 3.6 | < .05 |
| CD38 | 44.1 ± 6.5 | 19.5 ± 4.4 | < .001 |
| ZAP-70 | 27.5 ± 5.6 | 7.1 ± 2.9 | < .001 |
Data are mean ± SE of the percentage of CD19+CD5+ cells from U-CLL or M-CLL cases expressing particular marker.
NS indicates not significant.